Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 31 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Body mass index and overall survival in patients with gastric cancer: stage-specific associations and prognostic implications
    Sijing Zhou, Dong Yu, Xiaojie Wang +3
    Frontiers in NutritionPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. From therapeutic pathways to patient archetypes: a latent class analysis framework for Value-Based Healthcare benchmarking
    Maialen Otamendi, Itxaso Alayo, Ania Gorostiza +3
    Frontiers in Health ServicesPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Lower peripheral T- and NK-cell counts are associated with systemic inflammation and nutritional status in hospitalized gastrointestinal surgery patients
    Zhi Duan, Xiangjuan Jiao, Ning Wang +5
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Positive psychological resources and support needs among patients with gastric cancer experiencing fear of cancer recurrence during chemotherapy: a qualitative study
    Wanjun Zhao, Yumei Huang, Yue Fan +2
    Frontiers in PsychologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  5. Giant hypervascular atypical lipomatous tumor/well-differentiated liposarcoma of the cervicodorsal region: a case report
    Zhonghai Liao, Feng Qin, Song Wang +2
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  6. Clinical and microbiological characteristics of abscesses in patients with malignancy and factors associated with 90-day mortality
    Huseyin Gencer, Fahriye Tugba Kos, Mustafa Guven +4
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. A real-world single-center study on the effects of low-volume polyethylene glycol electrolyte solution and rhubarb for colonoscopy preparation: quality, tolerance, and experience
    Caiwen Tan
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  8. Parity, breastfeeding, and reproductive timing are associated with tumour-infiltrating lymphocytes in hormone receptor-negative breast cancer: a population-based cohort study
    E. Gabrielsen, A. Wirsing, T. Wilsgaard +8
    ESMO OpenPeer-reviewedCC BY 4.0Full textOncologyPMC
  9. Rapidly progressive adult-onset hydroa vacciniforme-like lymphoproliferative disorder associated with Epstein-Barr virus: a case report.
    Joseph Deng, Gideon Wolf, Parth Contractor +3
    Leukemia research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  10. Clinical utility of circulating tumor cell PD-L1 expression for predicting immunotherapeutic response and prognosis in esophageal cancer
    Jing Li, Yueze Li, Lin Chen +4
    The Journal of Liquid BiopsyPeer-reviewedCC BYFull textOncologyDOAJEurope PMCPMC
  11. Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first-line therapy
    J.W. Lee, P.E. Oberstein, J.D. Goldberg +9
    ESMO Gastrointestinal OncologyPeer-reviewedCC BY-NC-NDFull textOncologyDOAJEurope PMCEurope PMCPMC
  12. Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
    Chetan C Oturkar, Junhoung Park J, Iqbal Ijaz +21
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  13. Pan-pediatric brain tumor microRNA networks define immune microenvironment states and responses to CAR T-cell therapy
    K. Coleman, R. J. Corbett, Z. Yi +5
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  14. Expanding Therapeutic Target Space from Genes to Disease-Relevant Molecular Forms with Agent3Diso
    F. T. JIANG, R. Zhao
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  15. AI-driven phenotypic profiling of organoids
    Y. Wang, Y. Sun, X. Jin
    bioRxivPreprintCC BYFull textOncologybioRxiv
  16. Sex Differences in DNA Methylation and Gene Expression Reveal Distinct Molecular Programs in Muscle-Invasive Bladder Cancer
    Bhavisha Doshi, Eduardo Cortes Gomez, Barbara A. Foster +4
    bioRxivPreprintCC BY-NCFull textOncologybioRxivPMC
  17. Development and design rules for a modular human peptide-tag adaptor CAR T cell system
    A. H. Joechner, M. Mach, M. Yeh +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  18. Circulating extracellular vesicles display immunotherapeutic targets and complement circulating tumor DNA in high-risk neuroblastoma
    M. Auber, A. Nejaime, H.-D. Chang +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  19. Stromal control of sympathetic rewiring in metastatic lymph nodes
    J. Li, X. Zhang, G.-H. Su +23
    bioRxivPreprintCC BYFull textOncologybioRxiv
  20. A scalable in vitro cell competition model identifies preleukemic super competitor clones
    L. Cabrera-Cosme, J. A. Rubio-Lara, E. Bennett +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. Small molecules targeting BRCA1-deficient cancer cells
    Arunasalam Navaraj, Shengliang Zhang, Chris Egg-Krings +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  22. SPATNIC enables H&E-grounded cancer-cell identification across spatial and single-cell transcriptomic modalities in colorectal cancer
    S. A. Sakai, R. Nomura, M. Ohira +18
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  23. DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface
    Gamze Bildik, Hailing Yang, Weiqun Mao +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  24. ResponseVerdict overturns computationally validated immunotherapy signatures, recovers their missed responders and outperforms every published response predictor
    H. Jiang, P. Liu, F. Gao +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  25. Cytoplasmic localization of 5hmC reveals RNA hydroxymethylation in breast cancer
    J. Wen, L. Del Bel Belluz, S. Ottaviani +11
    bioRxivPreprintCC BYFull textOncologybioRxiv